Page last updated: 2024-08-24

ziprasidone and Overweight

ziprasidone has been researched along with Overweight in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beszlej, A; Bienkowski, P; Frydecka, D; Grzywacz, A; Mierzejewski, P; Samochowiec, A; Samochowiec, J; Trześniowska-Drukała, B; Tybura, P	1
Chandler, RA; Childers, ME; Hill, SJ; Ketter, TA; Rasgon, NL; Wang, PW	1

Trials

1 trial(s) available for ziprasidone and Overweight

Article	Year
Pharmacogenetics of adverse events in schizophrenia treatment: comparison study of ziprasidone, olanzapine and perazine. Psychiatry research, 2014, Oct-30, Volume: 219, Issue:2 Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Catechol O-Methyltransferase; Dopamine Plasma Membrane Transport Proteins; Female; Genotype; GluK3 Kainate Receptor; Humans; Male; Middle Aged; Monoamine Oxidase; Olanzapine; Overweight; Perazine; Piperazines; Polymorphism, Genetic; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Receptors, Kainic Acid; Schizophrenia, Paranoid; Serotonin Plasma Membrane Transport Proteins; Thiazoles; Weight Gain; Young Adult	2014

Article

Year

Pharmacogenetics of adverse events in schizophrenia treatment: comparison study of ziprasidone, olanzapine and perazine.

Psychiatry research, 2014, Oct-30, Volume: 219, Issue:2

Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Catechol O-Methyltransferase; Dopamine Plasma Membrane Transport Proteins; Female; Genotype; GluK3 Kainate Receptor; Humans; Male; Middle Aged; Monoamine Oxidase; Olanzapine; Overweight; Perazine; Piperazines; Polymorphism, Genetic; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Receptors, Kainic Acid; Schizophrenia, Paranoid; Serotonin Plasma Membrane Transport Proteins; Thiazoles; Weight Gain; Young Adult

2014

Other Studies

1 other study(ies) available for ziprasidone and Overweight

Article	Year
Open adjunctive ziprasidone associated with weight loss in obese and overweight bipolar disorder patients. Journal of psychiatric research, 2011, Volume: 45, Issue:8 Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Bipolar Disorder; Blood Glucose; Body Mass Index; Dose-Response Relationship, Drug; Fasting; Female; Humans; Male; Middle Aged; Obesity; Overweight; Piperazines; Prospective Studies; Thiazoles; Waist Circumference; Weight Loss	2011

Article

Year

Open adjunctive ziprasidone associated with weight loss in obese and overweight bipolar disorder patients.

Journal of psychiatric research, 2011, Volume: 45, Issue:8

Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Bipolar Disorder; Blood Glucose; Body Mass Index; Dose-Response Relationship, Drug; Fasting; Female; Humans; Male; Middle Aged; Obesity; Overweight; Piperazines; Prospective Studies; Thiazoles; Waist Circumference; Weight Loss

2011